Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML
Status:
Terminated
Trial end date:
2017-02-16
Target enrollment:
Participant gender:
Summary
This is a pilot efficacy assessment clinical trial of vosaroxin and cytarabine for the
treatment of adults 60 years of age or older with previously untreated acute myeloid
leukemia. A total of 17 evaluable patients are planned to be treated on the study.